Your browser doesn't support javascript.
loading
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
Torkildsen, Ø; Myhr, K-M; Bø, L.
Affiliation
  • Torkildsen Ø; Department of Clinical Medicine, KG Jebsen MS Research Centre, University of Bergen, Bergen, Norway.
  • Myhr KM; Department of Neurology, Norwegian Multiple Sclerosis Competence Centre, Haukeland University Hospital, Bergen, Norway.
  • Bø L; Department of Clinical Medicine, KG Jebsen MS Research Centre, University of Bergen, Bergen, Norway.
Eur J Neurol ; 23 Suppl 1: 18-27, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26563094
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Clinical Trials, Phase III as Topic / Multiple Sclerosis, Relapsing-Remitting / Immunologic Factors Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2016 Type: Article Affiliation country: Norway
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Randomized Controlled Trials as Topic / Clinical Trials, Phase III as Topic / Multiple Sclerosis, Relapsing-Remitting / Immunologic Factors Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur J Neurol Journal subject: NEUROLOGIA Year: 2016 Type: Article Affiliation country: Norway